Adam C ElNaggar (Adam ElNaggar)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 4

Top Topics

Pulmonary Tuberculosis

Tyrosine Kinase

End Stage Renal Disease

Top Venues

Journal of personalized medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

University of Tennessee West Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tennessee West Cancer Center Aug 01 2016

United States

Assistant Professor :: Gynecologic Oncology

Publications

Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, Georgios I Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, Tine G Andreasen, Naja Lange, Shruti Sharma, Adam C ElNaggar, Minetta C Liu, Himanshu Sethi, Alexey Aleshin, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ari VanderWalde, Axel Grothey, Daniel Vaena, Gregory Vidal, Adam C ElNaggar, Gabriella Bufalino, Lee Schwartzberg
Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting. Journal of personalized medicine 10 (4) (2020)
Michael A Ulm, Tiffany M Redfern, Ben R Wilson, Suriyan Ponnusamy, Sarah Asemota, Patrick W Blackburn, Yinan Wang, Adam C ElNaggar, Ramesh Narayanan
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. Journal of personalized medicine 10 (4) (2020)
Adam C ElNaggar, John L Hays, James L Chen
Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series. PloS one 11 (6) (2016)